Literature DB >> 11870434

Characterization of low-intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging.

M Cruz1, K Tsuda, Y Narumi, Y Kuroiwa, T Nose, Y Kojima, A Okuyama, S Takahashi, K Aozasa, J O Barentsz, H Nakamura.   

Abstract

The aim of this study was to determine which morphological features of low-intensity lesions in the peripheral zone of the prostate are predictable of prostate cancer on pre-biopsy T2-weighted integrated endorectal phased-array MR images. The MR examinations were performed in 69 consecutive patients with elevated level of prostate-specific antigen (>4 ng/ml) and/or a positive digital rectal examination before transperineal 12-site biopsy. Two radiologists evaluated presence of lesions, their morphological features, and possibility of malignancy in divided into four sections of the peripheral zone. Imaging analysis findings were compared with biopsy results. Discriminative features were selected by stepwise logistic regression. Descriptive statistics and receiver operating characteristics (ROC) curves were also calculated. Sixty-eight benign lesions and 23 malignant lesions were found. Wedge shape and diffuse extensions without mass effect were significantly associated with benignity ( P=0.0105 and 0.002, respectively). Lesion size was significantly associated with malignancy ( P=0.0001). For evaluating probability of malignancy for lesions, regression model showed a comparable accuracy with the total impression for the readers in ROC analysis (Az 0.9095 vs 0.9266, respectively). Wedge shape, diffuse extension without mass effect, and size are the morphological features of low-intensity lesions in the peripheral zone on pre-biopsy T2-weighted MR images that give the best prediction of malignancy.

Entities:  

Mesh:

Year:  2001        PMID: 11870434     DOI: 10.1007/s003300101044

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  18 in total

1.  Dynamic contrast-enhanced MRI of the prostate: is this the way to proceed for characterization of prostatic carcinoma?

Authors:  R H Oyen
Journal:  Eur Radiol       Date:  2003-05       Impact factor: 5.315

2.  Cost-analysis of staging methods for lymph nodes in patients with prostate cancer: MRI with a lymph node-specific contrast agent compared to pelvic lymph node dissection or CT.

Authors:  Anke M Hövels; Roel A M Heesakkers; Eddy M Adang; Gerrit J Jager; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2004-07-13       Impact factor: 5.315

3.  Reproducibility of image interpretation in MRI of the prostate: application of the sextant framework by two different radiologists.

Authors:  Ullrich Mueller-Lisse; Ulrike Mueller-Lisse; Juergen Scheidler; Gerhardt Klein; Maximilian Reiser
Journal:  Eur Radiol       Date:  2005-04-20       Impact factor: 5.315

4.  MR-compatible assistance system for punction in a high-field system: device and feasibility of transgluteal biopsies of the prostate gland.

Authors:  Stephan Zangos; Christopher Herzog; Katrin Eichler; Renate Hammerstingl; Andreas Lukoschek; Stefanie Guthmann; Bernd Gutmann; Uwe Joseph Schoepf; Phillip Costello; Thomas J Vogl
Journal:  Eur Radiol       Date:  2006-10-10       Impact factor: 5.315

5.  Multiparametric MRI Features and Pathologic Outcome of Wedge-Shaped Lesions in the Peripheral Zone on T2-Weighted Images of the Prostate.

Authors:  Aritrick Chatterjee; Sevil Tokdemir; Alexander J Gallan; Ambereen Yousuf; Tatjana Antic; Gregory S Karczmar; Aytekin Oto
Journal:  AJR Am J Roentgenol       Date:  2018-11-07       Impact factor: 3.959

6.  Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy.

Authors:  C Onal; S Sonmez; G Erbay; O C Guler; G Arslan
Journal:  Br J Radiol       Date:  2013-12-06       Impact factor: 3.039

7.  Dosimetric benefit of DMLC tracking for conventional and sub-volume boosted prostate intensity-modulated arc radiotherapy.

Authors:  Tobias Pommer; Marianne Falk; Per R Poulsen; Paul J Keall; Ricky T O'Brien; Peter Meidahl Petersen; Per Munck af Rosenschöld
Journal:  Phys Med Biol       Date:  2013-03-14       Impact factor: 3.609

8.  Prostate diffusion-weighted imaging at 3T: effect of intravenous gadobutrol administration.

Authors:  Chan Kyo Kim; Jung Jae Park; Byung Kwan Park
Journal:  Eur Radiol       Date:  2015-08-09       Impact factor: 5.315

9.  MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results.

Authors:  Stephan Zangos; Katrin Eichler; Kerstin Engelmann; Mukhtiar Ahmed; Sebastian Dettmer; Christopher Herzog; Wasilios Pegios; A Wetter; Thomas Lehnert; Martin G Mack; Thomas J Vogl
Journal:  Eur Radiol       Date:  2004-09-04       Impact factor: 5.315

10.  T2-weighted MR imaging of prostate cancer: multishot echo-planar imaging vs fast spin-echo imaging.

Authors:  Tsutomu Tamada; Teruki Sone; Kiyohisa Nagai; Yoshimasa Jo; Masayuki Gyoten; Shigeki Imai; Yasumasa Kajihara; Masao Fukunaga
Journal:  Eur Radiol       Date:  2003-10-18       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.